Jun Liu
Fortuna: 2 M $ al 31/07/2026
Fortuna: 2 M $ al 31/07/2026
Dr. Jun Liu was previously employed as a CEO, Executive Director & Chief Scientific Officer by BioDlink International Co., Ltd. and an Executive Director-Biologics Research by Shanghai ChemPartner Co., Ltd. He received his undergraduate degree from the University of Science & Technology of China and a doctorate degree from the University of California, Davis.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/06/2025 | 5.699.999 ( 0,74 % ) | 2 M $ | 31/07/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| BIODLINK INTERNATIONAL COMPANY LIMITED | Director Ejecutivo | 13/10/2025 |
Shanghai ChemPartner Co., Ltd.
Shanghai ChemPartner Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization | Corporate Officer/Principal | 01/10/2016 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
University of California, Davis
University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Science & Technology of China
University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai ChemPartner Co., Ltd.
Shanghai ChemPartner Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization | Commercial Services |
TOT BIOPHARM International Co. Ltd.
TOT BIOPHARM International Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets anti-tumor drugs | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.